C2 GROUP, LLC for AMGEN USA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2010 | $50,000 | Replaced |
| 2nd Quarter - Report (this page) | Jul 20, 2010 | $50,000 | Replaced |
| 2nd Quarter - Amendment | Jul 20, 2010 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement Issues Implementation of P.L. 111-148, Patient Protection and Affordable Care Act (End Stage Renal Disease) Implementation of P.L. 111-152, Reconciliation Act of 2010 (End Stage Renal Disease)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G HUNTER BATES | — |
| LESLEY ELLIOTT | — |
Copyright/Patent/Trademark CPT
Intellectual Property Issues S. 515 and S. 610, Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| G HUNTER BATES | — |
| LESLEY ELLIOTT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.